Study Details

Healthy, Non-Smoking Adults

Study Number

8407-182-G2

Group

2

Gender

both

Age

18-55

Location

Dallas, Texas

Compensation

$6097

Study Dates

Jul. 21 - Aug. 18, 2019

Additional Information

The purpose of this study is to evaluate the effects on the amount of omaveloxolone after taking gemfibrozil in healthy subjects. In addition, the safety and tolerability of the study drugs, when given together, will be evaluated. Omaveloxolone is an investigational drug being developed for the treatment of a disease called Friedreich’s ataxia, which is an inherited disease of the nervous system.

Volunteers must be:
• Healthy, Non-Smoking Adults, Age 18-55
• BMI (body mass index) 18-32
• Join us for 1 stay of 23 nights plus 1 follow-up phone call
• Compensation up to $6,097 may be provided for time and participation

Call us today! - (469) 914-8330

Details

Group: 2
Screening Dates: Jul 2,3,5,8,10,11,12
Check-in: 21-Jul-2019
Check-out: 13-Aug-2019
Follow-up Phone Call: 18-Aug-2019

Study Number

8407-182-G2

Group

2

Gender

both

Age

18-55

Location

Dallas, Texas

Compensation

$6097

Study Dates

Jul. 21 - Aug. 18, 2019

Additional Information

The purpose of this study is to evaluate the effects on the amount of omaveloxolone after taking gemfibrozil in healthy subjects. In addition, the safety and tolerability of the study drugs, when given together, will be evaluated. Omaveloxolone is an investigational drug being developed for the treatment of a disease called Friedreich’s ataxia, which is an inherited disease of the nervous system.

Volunteers must be:
• Healthy, Non-Smoking Adults, Age 18-55
• BMI (body mass index) 18-32
• Join us for 1 stay of 23 nights plus 1 follow-up phone call
• Compensation up to $6,097 may be provided for time and participation

Call us today! - (469) 914-8330

Details

Group: 2
Screening Dates: Jul 2,3,5,8,10,11,12
Check-in: 21-Jul-2019
Check-out: 13-Aug-2019
Follow-up Phone Call: 18-Aug-2019

Calculate Your BMI!

Calculate Your BMI!